Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Huppler Hullsiek

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2018
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in UgandaElizabeth Nalintya, David B Meya, Sarah Lofgren, et al.
AIDS (London, England)|November 5, 2008
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenZoe Fox, Andrew Phillips, Cal Cohen, et al.
Clinical Trials (London, England)|October 25, 2019
A randomized evaluation of on-site monitoring nested in a multinational randomized trialNicole Wyman Engen, Kathy Huppler Hullsiek, Waldo H Belloso, et al.
Plos One|January 1, 2019
Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortalityAbdu Kisekka Musubire, David B Meya, Joshua Rhein, et al.
The Journal of Infectious Diseases|February 6, 2019
The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral TherapyOrnella Sortino, Kathy Huppler Hullsiek, Elizabeth Richards, et al.
BMC Infectious Diseases|June 28, 2019
Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort studyCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Vaccine|October 5, 2010
The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infectionNancy F Crum-Cianflone, Mollie Roediger, Kathy Huppler Hullsiek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2025
Effectiveness of a national reflex laboratory cryptococcal antigen screening programme for people with advanced HIV disease in South Africa: a nationwide-sampled cohort study (CAST-NET)Nelesh P Govender, Greg S Greene, Kathy Huppler Hullsiek, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in UgandaKyle D Smith, Beatrice Achan, Kathy Huppler Hullsiek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapyRichard M Novak, Li Chen, Rodger D MacArthur, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2018
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in UgandaElizabeth Nalintya, David B Meya, Sarah Lofgren, et al.
AIDS (London, England)|November 5, 2008
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimenZoe Fox, Andrew Phillips, Cal Cohen, et al.
Clinical Trials (London, England)|October 25, 2019
A randomized evaluation of on-site monitoring nested in a multinational randomized trialNicole Wyman Engen, Kathy Huppler Hullsiek, Waldo H Belloso, et al.
Plos One|January 1, 2019
Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortalityAbdu Kisekka Musubire, David B Meya, Joshua Rhein, et al.
The Journal of Infectious Diseases|February 6, 2019
The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral TherapyOrnella Sortino, Kathy Huppler Hullsiek, Elizabeth Richards, et al.
BMC Infectious Diseases|June 28, 2019
Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort studyCynthia Ahimbisibwe, Richard Kwizera, Jane Frances Ndyetukira, et al.
Vaccine|October 5, 2010
The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infectionNancy F Crum-Cianflone, Mollie Roediger, Kathy Huppler Hullsiek, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 15, 2025
Effectiveness of a national reflex laboratory cryptococcal antigen screening programme for people with advanced HIV disease in South Africa: a nationwide-sampled cohort study (CAST-NET)Nelesh P Govender, Greg S Greene, Kathy Huppler Hullsiek, et al.
Antimicrobial Agents and Chemotherapy|September 2, 2015
Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in UgandaKyle D Smith, Beatrice Achan, Kathy Huppler Hullsiek, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapyRichard M Novak, Li Chen, Rodger D MacArthur, et al.
Pageof 4